Simone Keller

Munich, BY 81675, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.

Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.

Journal: BMC cancer

Published: August 14, 2021

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.

Journal: BMC cancer

Published: November 23, 2020

Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.

Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.

Journal: BMC cancer

Published: December 18, 2019

Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines.

Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines.

Journal: PLoS computational biology

Published: May 27, 2019

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Journal: Molecular oncology

Published: August 22, 2017

Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.

Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.

Journal: BMC cancer

Published: May 16, 2017

Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Journal: Journal of cancer research and clinical oncology

Published: September 08, 2016

Associating approximate paths and temporal sequences of noisy detections: Application to the recovery of spatio-temporal cancer cell trajectories.

Associating approximate paths and temporal sequences of noisy detections: Application to the recovery of spatio-temporal cancer cell trajectories.

Journal: Medical image analysis

Published: June 03, 2014

Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines.

Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines.

Journal: Journal of cancer research and clinical oncology

Published: February 01, 2012

Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines.

Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines.

Journal: International journal of oncology

Published: December 29, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026